MA29333B1 - Preparations pharmaceutiques d'aerosol pour aerosols-doseurs pressurises contenant un agent sequestrant - Google Patents
Preparations pharmaceutiques d'aerosol pour aerosols-doseurs pressurises contenant un agent sequestrantInfo
- Publication number
- MA29333B1 MA29333B1 MA30220A MA30220A MA29333B1 MA 29333 B1 MA29333 B1 MA 29333B1 MA 30220 A MA30220 A MA 30220A MA 30220 A MA30220 A MA 30220A MA 29333 B1 MA29333 B1 MA 29333B1
- Authority
- MA
- Morocco
- Prior art keywords
- dosers
- pharmaceutical preparations
- pressurized aerosols
- aerosol pharmaceutical
- containing sequestrant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
LA PRÉSENTE INVENTION SE RAPPORTE À UNE PRÉPARATION DE SOLUTION POUR AÉROSOL DESTINÉE À ÊTRE UTILISÉE DANS UN INHALATEUR AÉROSOL, QUI CONTIENT AU MOINS UN INGRÉDIENT ACTIF SÉLECTIONNÉ PARMI LES 20-CÉTOSTÉROÏDES ET LES DÉRIVÉS DE LA QUINOLINONE, UN PROPULSEUR CONTENANT UN HYDROFLUOROALCANE ET UN COSOLVANT, STABILISÉS PAR L'AJOUT D'UNE DOSE SPÉCIFIQUE D'UN AGENT SÉQUESTRANT.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05004233 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29333B1 true MA29333B1 (fr) | 2008-03-03 |
Family
ID=36490097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30220A MA29333B1 (fr) | 2005-02-25 | 2007-09-11 | Preparations pharmaceutiques d'aerosol pour aerosols-doseurs pressurises contenant un agent sequestrant |
Country Status (23)
Country | Link |
---|---|
US (1) | US8877164B2 (fr) |
EP (1) | EP1850831B1 (fr) |
JP (1) | JP5259193B2 (fr) |
KR (1) | KR101313959B1 (fr) |
CN (1) | CN101119706B (fr) |
AR (2) | AR054230A1 (fr) |
AU (1) | AU2006218177B2 (fr) |
BR (1) | BRPI0607990A2 (fr) |
CA (1) | CA2594127C (fr) |
EA (1) | EA013405B1 (fr) |
GE (1) | GEP20105040B (fr) |
HK (1) | HK1116337A1 (fr) |
IL (1) | IL184449A0 (fr) |
MA (1) | MA29333B1 (fr) |
MX (1) | MX2007010396A (fr) |
NO (1) | NO20074854L (fr) |
NZ (1) | NZ556376A (fr) |
PE (1) | PE20061011A1 (fr) |
SG (1) | SG159550A1 (fr) |
TN (1) | TNSN07289A1 (fr) |
UA (1) | UA92732C2 (fr) |
WO (1) | WO2006089656A2 (fr) |
ZA (1) | ZA200706870B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005008946D1 (de) * | 2004-05-13 | 2008-09-25 | Chiesi Farma Spa | Medizinische aerosolformulierungen mit verbesserter chemischer stabilität |
GB201200525D0 (en) * | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
RU2519653C1 (ru) * | 2013-02-27 | 2014-06-20 | Шолекс Девелопмент Гмбх, | Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания |
US10034866B2 (en) * | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
US11642372B2 (en) | 2020-05-01 | 2023-05-09 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
US11826382B2 (en) | 2020-05-01 | 2023-11-28 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100312357B1 (ko) * | 1992-12-09 | 2002-04-24 | 데이비드 이. 프랭크하우저 | 안정화된약제의에어로졸용액제제 |
ZA939195B (en) * | 1992-12-09 | 1995-06-08 | Boehringer Ingelheim Pharma | Stabilized medicinal aerosol solution formulations |
AU680967B2 (en) | 1993-12-20 | 1997-08-14 | Minnesota Mining And Manufacturing Company | Flunisolide aerosol formulations |
JPH11507359A (ja) * | 1995-06-07 | 1999-06-29 | ローヌ−プーラン ローラー ファーマシューティカルズ インコーポレイテッド | 安定化ステロイド組成物 |
EE03509B2 (et) * | 1995-06-27 | 2015-02-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
AU2001257621A1 (en) * | 2000-05-17 | 2001-11-26 | Chrysalis Technologies, Incorporated | Stabilized budesonide solution and method for making same |
ME00220B (me) * | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom |
ME00077B (fr) * | 2002-03-01 | 2010-06-10 | Chiesi Farm Spa | Preparation superfine de formoterol |
US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
WO2003087097A1 (fr) | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicament contenant des betamimetiques et un nouvel anticholinergique |
US20040058950A1 (en) | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
DE10230769A1 (de) | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren |
DE10237739A1 (de) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
AU2003291634A1 (en) * | 2002-10-08 | 2004-05-04 | Sepracor Inc. | Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
EP1595531A1 (fr) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression |
-
2006
- 2006-02-13 NZ NZ556376A patent/NZ556376A/en not_active IP Right Cessation
- 2006-02-13 SG SG201000998-3A patent/SG159550A1/en unknown
- 2006-02-13 GE GEAP200610279A patent/GEP20105040B/en unknown
- 2006-02-13 BR BRPI0607990-3A patent/BRPI0607990A2/pt not_active IP Right Cessation
- 2006-02-13 WO PCT/EP2006/001287 patent/WO2006089656A2/fr active Application Filing
- 2006-02-13 KR KR1020077016131A patent/KR101313959B1/ko not_active IP Right Cessation
- 2006-02-13 CA CA2594127A patent/CA2594127C/fr not_active Expired - Fee Related
- 2006-02-13 EP EP06706899.9A patent/EP1850831B1/fr active Active
- 2006-02-13 AU AU2006218177A patent/AU2006218177B2/en not_active Ceased
- 2006-02-13 JP JP2007556521A patent/JP5259193B2/ja not_active Expired - Fee Related
- 2006-02-13 EA EA200701805A patent/EA013405B1/ru not_active IP Right Cessation
- 2006-02-13 CN CN2006800047251A patent/CN101119706B/zh not_active Expired - Fee Related
- 2006-02-13 MX MX2007010396A patent/MX2007010396A/es active IP Right Grant
- 2006-02-13 UA UAA200707949A patent/UA92732C2/ru unknown
- 2006-02-17 PE PE2006000199A patent/PE20061011A1/es not_active Application Discontinuation
- 2006-02-23 AR AR20060100670A patent/AR054230A1/es not_active Application Discontinuation
- 2006-02-24 US US11/361,562 patent/US8877164B2/en not_active Expired - Fee Related
-
2007
- 2007-07-05 IL IL184449A patent/IL184449A0/en unknown
- 2007-07-24 TN TNP2007000289A patent/TNSN07289A1/en unknown
- 2007-08-16 ZA ZA200706870A patent/ZA200706870B/xx unknown
- 2007-09-11 MA MA30220A patent/MA29333B1/fr unknown
- 2007-09-24 NO NO20074854A patent/NO20074854L/no not_active Application Discontinuation
-
2008
- 2008-06-12 HK HK08106480.6A patent/HK1116337A1/xx not_active IP Right Cessation
-
2015
- 2015-04-06 AR ARP150101030A patent/AR099963A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL184449A0 (en) | 2007-10-31 |
NZ556376A (en) | 2010-01-29 |
EP1850831A2 (fr) | 2007-11-07 |
EA013405B1 (ru) | 2010-04-30 |
AR054230A1 (es) | 2007-06-13 |
WO2006089656A3 (fr) | 2006-12-21 |
KR101313959B1 (ko) | 2013-10-02 |
PE20061011A1 (es) | 2006-12-08 |
HK1116337A1 (en) | 2008-12-19 |
EP1850831B1 (fr) | 2015-12-02 |
CA2594127A1 (fr) | 2006-08-31 |
ZA200706870B (en) | 2008-11-26 |
US8877164B2 (en) | 2014-11-04 |
CN101119706B (zh) | 2013-04-17 |
EA200701805A1 (ru) | 2008-02-28 |
SG159550A1 (en) | 2010-03-30 |
AR099963A2 (es) | 2016-08-31 |
WO2006089656A2 (fr) | 2006-08-31 |
NO20074854L (no) | 2007-09-24 |
KR20070107002A (ko) | 2007-11-06 |
US20060193785A1 (en) | 2006-08-31 |
BRPI0607990A2 (pt) | 2009-10-27 |
AU2006218177A1 (en) | 2006-08-31 |
JP5259193B2 (ja) | 2013-08-07 |
GEP20105040B (en) | 2010-07-12 |
TNSN07289A1 (en) | 2008-12-31 |
JP2008537729A (ja) | 2008-09-25 |
CN101119706A (zh) | 2008-02-06 |
MX2007010396A (es) | 2007-10-19 |
UA92732C2 (ru) | 2010-12-10 |
AU2006218177B2 (en) | 2012-04-12 |
CA2594127C (fr) | 2013-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29333B1 (fr) | Preparations pharmaceutiques d'aerosol pour aerosols-doseurs pressurises contenant un agent sequestrant | |
MA27710A1 (fr) | Formulations pharmaceutiques liquides de palonosetrone | |
MA33836B1 (fr) | Compositions pharmaceutiques contenant des ligands des récepteurs sigma | |
MA29744B1 (fr) | Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree | |
MA29606B1 (fr) | Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l'eugenol, le borneol et le carvacrol | |
PT1033981E (pt) | Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos | |
TNSN07425A1 (fr) | Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol,l'eugenol, le thymol, le borneol, le carvacrol, et les ionones alpha-et-beta-. | |
TNSN07476A1 (fr) | Derives de n-(pyridine -2- yl) - sulfonamide | |
CY1119188T1 (el) | Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας | |
NO20061925L (no) | Farmasoytiske preparater for forebyggelse av overdose eller misbruk | |
WO2006124047A3 (fr) | Formulations pharmaceutiques contenant des microparticules ou des nanoparticules d'un agent d'administration | |
MA26877A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
TNSN07423A1 (fr) | Composition pharmaceutique comprenant un agent antiparasitaire, et un actif choisi parmi le carveol, le thymol, l'eugenol, le borneol, le carvacrol, l 'alpha-ionone ou le beta-ionone | |
CY1112523T1 (el) | Υγρες συνθεσεις κανναβινοειδων για χορηγηση σε βλεννογονο | |
MA29630B1 (fr) | Ingredient pharmaceutique actif du cannabinoide pour des formes de dosage ameliorees | |
BR0115965A (pt) | Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos | |
WO2005117895A3 (fr) | Compositions contenant de la meloxicame | |
PE20060771A1 (es) | Profarmaco de amida de gemcitabina y composiciones que lo contienen | |
MA27867A1 (fr) | Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. | |
MA27008A1 (fr) | Composition parenterale reconstituable contenant un inhibiteur de cox-2 | |
MA29969B1 (fr) | Formulations de quinolinones | |
CY1112637T1 (el) | Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης | |
MA38679A1 (fr) | Modulateurs du récepteur de cxcr7 | |
DK1359939T3 (da) | Sammensætning og fremgangsmåde til potensering af lægemidler | |
TW200634002A (en) | Chemical compounds |